Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 months

BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory bowel disease with recurrent episodes of debilitating symptoms negatively affecting work productivity and health-related quality of life (HRQoL). The use of biologics in UC treatment improves work and HRQoL but prospective long-term data...

Descripción completa

Detalles Bibliográficos
Autores principales: Teich, Niels, Grümmer, Harald, Jörgensen, Eric, Liceni, Thomas, Holtkamp-Endemann, Frank, Fischer, Tim, Hohenberger, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042988/
https://www.ncbi.nlm.nih.gov/pubmed/33845784
http://dx.doi.org/10.1186/s12876-021-01747-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042988/
https://www.ncbi.nlm.nih.gov/pubmed/33845784
http://dx.doi.org/10.1186/s12876-021-01747-z

Ejemplares similares